<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/63C3968A-F903-4D7A-8EFB-D9A237129852"><gtr:id>63C3968A-F903-4D7A-8EFB-D9A237129852</gtr:id><gtr:name>Marie Curie</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C932CFE-AAE2-4A8F-A53F-1C7EAC961997"><gtr:id>9C932CFE-AAE2-4A8F-A53F-1C7EAC961997</gtr:id><gtr:name>Harvard University</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/63C3968A-F903-4D7A-8EFB-D9A237129852"><gtr:id>63C3968A-F903-4D7A-8EFB-D9A237129852</gtr:id><gtr:name>Marie Curie</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/BEA4828F-8928-4218-A03B-20230708518C"><gtr:id>BEA4828F-8928-4218-A03B-20230708518C</gtr:id><gtr:firstName>Darerca</gtr:firstName><gtr:surname>Owen</gtr:surname><gtr:orcidId>0000-0003-0978-5425</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C9C732B3-337A-4410-86A9-C9A45AA70DE6"><gtr:id>C9C732B3-337A-4410-86A9-C9A45AA70DE6</gtr:id><gtr:firstName>Helen</gtr:firstName><gtr:surname>Mott</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700057"><gtr:id>3C5DB774-E73C-45D5-90C8-F72BBC8FC969</gtr:id><gtr:title>Structure/function analysis of the Ral/RLIP signalling pathway as a therapeutic target</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0700057</gtr:grantReference><gtr:abstractText>Our work addresses the relationship between structure and function in proteins involved in signalling within the cell. These proteins control many signal transmission pathways that become deregulated in cancer and other diseases. The proteins that we study are important in the progression of a cell from being normal to being cancerous, a process that requires a combination of increased growth and resistance to normal cell death. The protein that we are proposing to concentrate on here, RLIP-76, is involved in many processes. It is important for stress responses and also for bringing molecules into the cell, a process that is strictly controlled. Both of these pathways are important in cancer progression. RLIP-76 can also act as a pump that removes chemotherapy drugs from cells, making them less effective. If we can understand more about how RLIP-76 is activated in all of these different processes, we might be able to find ways to inhibit it; so one of the things we will look at is the mechanism of RLIP-76 activation. One of the most important things that proteins do in cells is to bind to other proteins. Although we know which proteins RLIP-76 binds to, we do not know how it binds to them. So one of the other major aims of our research is to understand how RLIP-76 binds to these other proteins. We do this by working out what the complex of RLIP-76 and its partner looks like in three dimenensions. This is crucial, because if we know how proteins bind to each other and which particular regions of the proteins are important for the interaction, it will be possible to design drugs that either prevent or enhance this binding,</gtr:abstractText><gtr:technicalSummary>It has been hypothesized that in non-cancerous cells proliferation and apoptosis are tightly associated and that the minimal platform to drive oncogenic transformation involves enhanced proliferation in conjunction with abrogation of apoptosis. The small GTPase RalA is required for anchorage-independent proliferation, while its close relative, RalB, is involved in the suppression of apoptosis, implying that Ral GTPases contribute to both critical aspects of carcinogenesis. This, coupled with the fact that loss of RalB function induces apoptosis in cancer cell lines but not normal cell lines, indicates that a potential therapeutic avenue directed against Ral-controlled signal transduction pathways would target both supports of the minimal platform simultaneously.

We will use a combination of structural biology, in vitro and in vivo analyses to investigate the interaction of the Ral effector RLIP-76 with RalB and with other signalling molecules. We have already solved the structures of the RLIP-76 GTPase binding domain (GBD) and RalB by NMR methods. We will now go on to solve the structure of the RLIP-76 GBD/RalB complex using NMR; initial spectra of the complex are of a high quality. We will use the structure of this complex to design Ral mutants that specifically abrogate binding to RLIP-76, while maintaining binding to other effector proteins (Exo84, Sec5, ZONAB and PLCdelta). These mutants will then be validated in vivo. We will go on to investigate the RhoGAP activity of RLIP-76 and its regulation by Ral and R-Ras GTPases. We will solve structures by NMR or X-ray crystallography of the RLIP-76 RhoGAP-GBD di-domain and of the RhoGAP/R-Ras complex. These analyses will shed light on the regulation of RLIP-76 by GTPases. We will also investigate the binding of the RLIP-76 C- and N-terminal regions to molecules involved in endocytosis (POB1 and AP2) and heat-shock (HSF1). We will use in vitro biochemical techniques to study these interactions and whether they bind independently or enhance or inhibit each other. We will also study the dependence of POB1, HSF1 and AP2 binding on Ral binding to RLIP-76. We will take these complexes forward to structural studies if possible.

The data that we generate will allow us to validate specific signalling pathways as therapeutic targets. The combination of structural information and thermodynamic parameters for these complexes could be used to aid design of small molecule inhibitors (or stabilisers as appropriate) of these interactions for therapeutic purposes.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>621072</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Marie Curie</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Marie Curie Research Institute</gtr:department><gtr:description>Ral and RLIP</gtr:description><gtr:id>CDBF99DE-26D5-47F9-9660-FA859581BB61</gtr:id><gtr:impact>The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.
Fenwick RB, Campbell LJ, Rajasekar K, Prasannan S, Nietlispach D, Camonis J, Owen D, Mott HR.
Structure. 2010 Aug 11;18(8):985-95</gtr:impact><gtr:outcomeId>Uj1tNLMPx5B-1</gtr:outcomeId><gtr:partnerContribution>Sharing unpublished data and providing constructs.</gtr:partnerContribution><gtr:piContribution>Structural and biochemical work to support the biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harvard University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Harvard Medical School</gtr:department><gtr:description>IQGAP</gtr:description><gtr:id>047F3C02-C904-4890-A99D-B79072AF5FFB</gtr:id><gtr:impact>The IQGAP1-Rac1 and IQGAP1-Cdc42 interactions: interfaces differ between the complexes.
Owen D, Campbell LJ, Littlefield K, Evetts KA, Li Z, Sacks DB, Lowe PN, Mott HR.
J Biol Chem. 2008 Jan 18;283(3):1692-704. Epub 2007 Nov 5.</gtr:impact><gtr:outcomeId>oWyMqdQ4heS-1</gtr:outcomeId><gtr:partnerContribution>Providing us with protein for experiments and sharing unpublished data</gtr:partnerContribution><gtr:piContribution>Biochemical assays to support biological data</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Alumni weekend</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>D04E9243-9117-4B6D-A62E-CE7FC911D517</gtr:id><gtr:impact>Around 30 people attended a lecture at the Alumni Weekend. It was particularly gratifying when several of the audience members came to talk to me afterwards about their personal experience with cancer.

I have been invited to talk to a network of Cambridge Alumni in Sheffield next year.</gtr:impact><gtr:outcomeId>Sg9b8Ry6YYN</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research horizons</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>B0A63A8C-52B4-4387-9E7E-057600723299</gtr:id><gtr:impact>Our work was featured in Research Horizons, a magazine that is distributed to academics and industry in the area.

This raised our profile in the local research community.</gtr:impact><gtr:outcomeId>thEbCz75Eak</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Summer school</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>27C5A988-85F4-4298-B4E5-A42F8DA54342</gtr:id><gtr:impact>30-40 sixth formers selected from a range of schools attended a summer school in Cambridge. I talked to them about deregulation in cancer and it sparked a lively discussion.

The summer school is increasingly popular and is always oversubscribed. Schools are targetted that do not traditionally send pupils to Cambridge and many students apply who would previously not have considered themselves suitable.</gtr:impact><gtr:outcomeId>fP7TZck6gmq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk to graduate students</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>DF796B10-6799-4F0B-80B0-625E4D58C4CD</gtr:id><gtr:impact>40 graduate students from both humanities and sciences attended a lecture after dinner. This sparked many questions.

Dissemination of science to a non-scientific audience.</gtr:impact><gtr:outcomeId>pJTjLiJ6sE7</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Chemical shifts of RalB (free and bound), RLIP76 GBD (free and bound) and the RLIP76 GBD-GAP didomain.</gtr:description><gtr:id>797E786D-0352-4A60-9C8F-EDC6E093BA20</gtr:id><gtr:impact>Chemical shifts are used by other NMR groups to study structures, dynamics and interactions. They are also used by drug designers who perform small molecule screens.</gtr:impact><gtr:outcomeId>PfXyQwS3cvX</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Chemical Shifts</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Structures of RalB and RalB-RLIP76 complexes.</gtr:description><gtr:id>1D6811CE-E46B-4FCB-A986-DB64578D1C4A</gtr:id><gtr:impact>Structures are used throughout the community - from biologists wishing to understand their data to computational chemists who are designing drugs.</gtr:impact><gtr:outcomeId>qdrqGMc5VPe</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Structures</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>900A5E93-CD73-4860-B12E-8606EFFD8022</gtr:id><gtr:title>The structure of the RLIP76 RhoGAP-Ral binding domain dyad: fixed position of the domains leads to dual engagement of small G proteins at the membrane.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfbf33388cb7a46760c7ac07f0e2431e"><gtr:id>cfbf33388cb7a46760c7ac07f0e2431e</gtr:id><gtr:otherNames>Rajasekar KV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_540e151e151cd05af</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1B61A23-ED99-4A04-916C-E08BE360ADEC</gtr:id><gtr:title>1H, 13C and 15N resonance assignments for the active conformation of the small G protein RalB in complex with its effector RLIP76.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>33F48243469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D1AFD94-B910-4508-BC0D-97F9D8B1C27A</gtr:id><gtr:title>Solution structure and dynamics of the small GTPase RalB in its active conformation: significance for effector protein binding.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>56cdaf33cbafa4.10870933</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2EB2FC90-AFE3-49A2-B566-837DFD52FDCE</gtr:id><gtr:title>Thermodynamic mapping of effector protein interfaces with RalA and RalB.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2edc3eb70cc9c9b3e24220c0f578f574"><gtr:id>2edc3eb70cc9c9b3e24220c0f578f574</gtr:id><gtr:otherNames>Campbell LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>doi_55f98498443dd957</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>02850FD1-C608-4AEC-8CE4-C9D07C2F475E</gtr:id><gtr:title>Structures of Ras superfamily effector complexes: What have we learnt in two decades?</gtr:title><gtr:parentPublicationTitle>Critical reviews in biochemistry and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88563c2b498f0d4802d54494205a2b95"><gtr:id>88563c2b498f0d4802d54494205a2b95</gtr:id><gtr:otherNames>Mott HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1040-9238</gtr:issn><gtr:outcomeId>56cdaf31ac43c2.36525738</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>735E7FE3-F0A1-4FF7-BEF3-ABFEE9B676B6</gtr:id><gtr:title>1H, 13C and 15N resonance assignments of the GTPase-activating (GAP) and Ral binding domains (GBD) of RLIP76 (RalBP1).</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cfbf33388cb7a46760c7ac07f0e2431e"><gtr:id>cfbf33388cb7a46760c7ac07f0e2431e</gtr:id><gtr:otherNames>Rajasekar KV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>56cdaf323a0bd0.65427853</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F6897915-F045-4256-95BF-4EEC18D63752</gtr:id><gtr:title>The RalB-RLIP76 complex reveals a novel mode of ral-effector interaction.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>56cdaf3315b693.74723557</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F993ED1F-4C9C-4617-9EFD-602E4640EFD3</gtr:id><gtr:title>1H, 13C and 15N resonance assignments for the small G protein RalB in its active conformation.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8545b8dfc93ad973cfd8f774729b9a3"><gtr:id>e8545b8dfc93ad973cfd8f774729b9a3</gtr:id><gtr:otherNames>Prasannan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>56cdaf35b89631.19939219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65422369-68CA-47F9-B46A-D0E97AA241F6</gtr:id><gtr:title>RLIP76 (RalBP1): The first piece of the structural puzzle.</gtr:title><gtr:parentPublicationTitle>Small GTPases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88563c2b498f0d4802d54494205a2b95"><gtr:id>88563c2b498f0d4802d54494205a2b95</gtr:id><gtr:otherNames>Mott HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>2154-1248</gtr:issn><gtr:outcomeId>56cdaf32cb46e2.00628687</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B7B22799-3BCD-4083-819D-B7AE57667DAB</gtr:id><gtr:title>Structure and function of RLIP76 (RalBP1): an intersection point between Ras and Rho signalling.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88563c2b498f0d4802d54494205a2b95"><gtr:id>88563c2b498f0d4802d54494205a2b95</gtr:id><gtr:otherNames>Mott HR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>pm_540e151e151dc733e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>762644BF-F61B-4BC9-B4E6-FD492071D33F</gtr:id><gtr:title>Resonance assignments for the RLIP76 Ral binding domain in its free form and in complex with the small G protein RalB.</gtr:title><gtr:parentPublicationTitle>Biomolecular NMR assignments</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08c75162adcd6ab92f507c2b9046ddcf"><gtr:id>08c75162adcd6ab92f507c2b9046ddcf</gtr:id><gtr:otherNames>Fenwick RB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1874-270X</gtr:issn><gtr:outcomeId>56cdaf3439f291.53999439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A78705D9-6B68-4B36-9FAB-AFA264693E7C</gtr:id><gtr:title>Mutational analysis reveals a single binding interface between RhoA and its effector, PRK1.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2127efd7b27610b8ed75ed6b5d35244"><gtr:id>d2127efd7b27610b8ed75ed6b5d35244</gtr:id><gtr:otherNames>Hutchinson CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>o6Ar5ZScdJ9</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700057</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>